Medical Weight Loss for Grand Prairie, Texas Residents
Grand Prairie, Texas residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Grand Prairie through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Grand Prairie Residents Choose New Hope Weight Loss
Grand Prairie patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Texas and beyond since 2020.
Medical weight loss for Grand Prairie is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.
Patients across Grand Prairie and the surrounding area connect with Dr. Sharma by secure video, wherever they live in Texas. We care for patients throughout the greater Grand Prairie area between Dallas and Fort Worth. Compounded semaglutide and tirzepatide ship directly to your door in Texas, and a licensed physician reviews every plan before anything is prescribed.
Our telehealth model serves Grand Prairie and communities across Texas with the same flat pricing and the same supervising physician. The first step is a $119 physician review; if you are not a candidate you are not charged, and compounded semaglutide starts at $166/month.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Grand Prairie
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Grand Prairie
Step 1: Complete the 2-minute quiz or the medical intake form online.
Step 2: Dr. Sharma reviews your history by secure video, typically within 48 hours.
Step 3: If you are a candidate and telehealth-eligible, the state-licensed 503(a) pharmacy ships your compounded medication to your Grand Prairie address in cold-pack packaging. Follow-ups and dose adjustments also happen by video, no travel required.
Frequently Asked Questions, Grand Prairie
How do I get treatment from Grand Prairie?
As a Grand Prairie, Texas patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Grand Prairie?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Grand Prairie in cold-pack packaging, no lines and no drive.
How much does it cost for Grand Prairie patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Grand Prairie do you serve?
We serve patients from across Grand Prairie by telehealth, including the greater Grand Prairie area between Dallas and Fort Worth.
Is my health information private as a Grand Prairie patient?
Yes. Your intake, video visits, and records are handled under HIPAA safeguards, and medication arrives in discreet packaging. Grand Prairie patients get the same confidentiality as any telehealth patient.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Grand Prairie, Texas by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.